

Artificial Intelligence Drug R&D Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Artificial Intelligence Drug R&D market is experiencing robust growth, driven by advancements in AI technologies and increased pharmaceutical investments. The market is projected to reach approximately $3.5 billion by 2025, reflecting a CAGR of over 30%. Current conditions favor innovation, streamlining drug discovery processes, and enhancing efficiency in research.
Request Sample Report
◍ IBM Watson
◍ BioXel
◍ Insilico Medicine
◍ Gatehouse Bio
◍ Google DeepMind
◍ Genpact Cora
◍ Cyclica Inc
◍ QuantumBlack
◍ Nq Medical
◍ Phenomic AI
◍ Palantir Technologies
The AI drug R&D market features key players like IBM Watson, Insilico Medicine, and DeepMind, leveraging AI for drug discovery, predictive modeling, and patient data analysis. These innovations enhance efficiency and reduce costs. Sales figures include IBM approximately $57 billion (2022) and Genpact around $4 billion (2022).
Request Sample Report
Drug Discovery
Precision Medicine
Request Sample Report
AI Platfrom
Analytics Service
Request Sample Report
$ X Billion USD